Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""De Kort AM"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-8 z 8
    Tytuł:
    Neuropsychiatric symptoms with focus on apathy and irritability in sporadic and hereditary cerebral amyloid angiopathy.
    Autorzy:
    Kaushik K; Neurology, Leiden University Medical Center (LUMC), Albinusdreef 2, 2300RC, Leiden, NL, the Netherlands. .
    de Kort AM; Neurology, Radboud University Medical Center (RUMC), Nijmegen, the Netherlands.; Donders Institute for Brain, Cognition and Behavior, Radboud University, Nijmegen, the Netherlands.
    van Dort R; Neurology, Leiden University Medical Center (LUMC), Albinusdreef 2, 2300RC, Leiden, NL, the Netherlands.
    van der Zwet RGJ; Neurology, Leiden University Medical Center (LUMC), Albinusdreef 2, 2300RC, Leiden, NL, the Netherlands.
    Siegerink B; Clinical Epidemiology, LUMC, Leiden, the Netherlands.
    Voigt S; Neurology, Leiden University Medical Center (LUMC), Albinusdreef 2, 2300RC, Leiden, NL, the Netherlands.; Radiology, LUMC, Leiden, the Netherlands.
    van Zwet EW; Biomedical Data Sciences, LUMC, Leiden, the Netherlands.
    van der Plas MC; Neurology, Leiden University Medical Center (LUMC), Albinusdreef 2, 2300RC, Leiden, NL, the Netherlands.
    Koemans EA; Neurology, Leiden University Medical Center (LUMC), Albinusdreef 2, 2300RC, Leiden, NL, the Netherlands.
    Rasing I; Neurology, Leiden University Medical Center (LUMC), Albinusdreef 2, 2300RC, Leiden, NL, the Netherlands.
    Kessels RPC; Donders Institute for Brain, Cognition and Behavior, Radboud University, Nijmegen, the Netherlands.; Medical Psychology and RUMC Alzheimer Center, Nijmegen, the Netherlands.; Vincent van Gogh Institute for Psychiatry, Venray, the Netherlands.
    Middelkoop HAM; Neurology, Leiden University Medical Center (LUMC), Albinusdreef 2, 2300RC, Leiden, NL, the Netherlands.; Institute of Psychology, Health and Neuropsychology, Leiden University, Leiden, the Netherlands.
    Schreuder FHBM; Neurology, Radboud University Medical Center (RUMC), Nijmegen, the Netherlands.; Donders Institute for Brain, Cognition and Behavior, Radboud University, Nijmegen, the Netherlands.
    Klijn CJM; Neurology, Radboud University Medical Center (RUMC), Nijmegen, the Netherlands.; Donders Institute for Brain, Cognition and Behavior, Radboud University, Nijmegen, the Netherlands.
    Verbeek MM; Neurology, Radboud University Medical Center (RUMC), Nijmegen, the Netherlands.; Donders Institute for Brain, Cognition and Behavior, Radboud University, Nijmegen, the Netherlands.; Laboratory Medicine, RUMC, Nijmegen, the Netherlands.
    Terwindt GM; Neurology, Leiden University Medical Center (LUMC), Albinusdreef 2, 2300RC, Leiden, NL, the Netherlands.
    van Etten ES; Neurology, Leiden University Medical Center (LUMC), Albinusdreef 2, 2300RC, Leiden, NL, the Netherlands.
    Wermer MJH; Neurology, Leiden University Medical Center (LUMC), Albinusdreef 2, 2300RC, Leiden, NL, the Netherlands.; Neurology, University Medical Center Groningen, Groningen, the Netherlands.
    Pokaż więcej
    Źródło:
    Alzheimer's research & therapy [Alzheimers Res Ther] 2024 Apr 06; Vol. 16 (1), pp. 74. Date of Electronic Publication: 2024 Apr 06.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Cerebral Amyloid Angiopathy, Familial*/complications
    Apathy*
    Cerebral Amyloid Angiopathy*/complications
    Cerebral Amyloid Angiopathy*/diagnostic imaging
    Male ; Humans ; Female ; Aged ; Child ; Prospective Studies ; Cerebral Hemorrhage/complications ; Magnetic Resonance Imaging
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Cerebrospinal fluid shotgun proteomics identifies distinct proteomic patterns in cerebral amyloid angiopathy rodent models and human patients.
    Autorzy:
    Vervuurt M; Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, 830 TML, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
    Schrader JM; Department of Biomedical and Pharmaceutical Sciences, George & Anne Institute for Neuroscience, University of Rhode Island, Kingston, RI, USA.
    de Kort AM; Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, 830 TML, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
    Kersten I; Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, 830 TML, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
    Wessels HJCT; Department of Human Genetics, Translational Metabolic Laboratory, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
    Klijn CJM; Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, 830 TML, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
    Schreuder FHBM; Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, 830 TML, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
    Kuiperij HB; Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, 830 TML, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
    Gloerich J; Department of Human Genetics, Translational Metabolic Laboratory, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
    Van Nostrand WE; Department of Biomedical and Pharmaceutical Sciences, George & Anne Institute for Neuroscience, University of Rhode Island, Kingston, RI, USA.
    Verbeek MM; Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, 830 TML, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands. .; Department of Human Genetics, Translational Metabolic Laboratory, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands. .
    Pokaż więcej
    Źródło:
    Acta neuropathologica communications [Acta Neuropathol Commun] 2024 Jan 08; Vol. 12 (1), pp. 6. Date of Electronic Publication: 2024 Jan 08.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Rodentia*
    Cerebral Amyloid Angiopathy*
    Humans ; Rats ; Animals ; Complement C1 Inhibitor Protein ; Amyloid beta-Peptides ; Proteomics ; Endopeptidases ; Biomarkers
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Plasma amyloid beta 42 is a biomarker for patients with hereditary, but not sporadic, cerebral amyloid angiopathy.
    Autorzy:
    de Kort AM; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, Nijmegen, 6500 HB, The Netherlands.
    Kuiperij HB; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, Nijmegen, 6500 HB, The Netherlands.
    Jäkel L; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, Nijmegen, 6500 HB, The Netherlands.
    Kersten I; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, Nijmegen, 6500 HB, The Netherlands.
    Rasing I; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
    van Etten ES; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
    van Rooden S; Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands.
    van Osch MJP; Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands.
    Wermer MJH; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
    Terwindt GM; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
    Schreuder FHBM; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, Nijmegen, 6500 HB, The Netherlands.
    Klijn CJM; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, Nijmegen, 6500 HB, The Netherlands.
    Verbeek MM; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, Nijmegen, 6500 HB, The Netherlands. .; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands. .
    Pokaż więcej
    Źródło:
    Alzheimer's research & therapy [Alzheimers Res Ther] 2023 Jun 03; Vol. 15 (1), pp. 102. Date of Electronic Publication: 2023 Jun 03.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
    MeSH Terms:
    Cerebral Amyloid Angiopathy*/diagnostic imaging
    Alzheimer Disease*/diagnosis
    Humans ; Amyloid beta-Peptides ; Peptide Fragments ; Biomarkers
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Decreased ratios of matrix metalloproteinases to tissue-type inhibitors in cerebrospinal fluid in sporadic and hereditary cerebral amyloid angiopathy.
    Autorzy:
    Vervuurt M; Department of Neurology, Cognition and Behaviour, Donders Institute for Brain, Radboud University Medical Center, P.O. Box 9101, 6500 HB , 830 TML, Nijmegen, The Netherlands.
    de Kort AM; Department of Neurology, Cognition and Behaviour, Donders Institute for Brain, Radboud University Medical Center, P.O. Box 9101, 6500 HB , 830 TML, Nijmegen, The Netherlands.
    Jäkel L; Department of Neurology, Cognition and Behaviour, Donders Institute for Brain, Radboud University Medical Center, P.O. Box 9101, 6500 HB , 830 TML, Nijmegen, The Netherlands.
    Kersten I; Department of Neurology, Cognition and Behaviour, Donders Institute for Brain, Radboud University Medical Center, P.O. Box 9101, 6500 HB , 830 TML, Nijmegen, The Netherlands.
    Abdo WF; Department of Intensive Care Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
    Schreuder FHBM; Department of Neurology, Cognition and Behaviour, Donders Institute for Brain, Radboud University Medical Center, P.O. Box 9101, 6500 HB , 830 TML, Nijmegen, The Netherlands.
    Rasing I; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
    Terwindt GM; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
    Wermer MJH; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
    Greenberg SM; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
    Klijn CJM; Department of Neurology, Cognition and Behaviour, Donders Institute for Brain, Radboud University Medical Center, P.O. Box 9101, 6500 HB , 830 TML, Nijmegen, The Netherlands.
    Kuiperij HB; Department of Neurology, Cognition and Behaviour, Donders Institute for Brain, Radboud University Medical Center, P.O. Box 9101, 6500 HB , 830 TML, Nijmegen, The Netherlands.
    Verbeek MM; Department of Neurology, Cognition and Behaviour, Donders Institute for Brain, Radboud University Medical Center, P.O. Box 9101, 6500 HB , 830 TML, Nijmegen, The Netherlands. .; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands. .
    Pokaż więcej
    Źródło:
    Alzheimer's research & therapy [Alzheimers Res Ther] 2023 Jan 30; Vol. 15 (1), pp. 26. Date of Electronic Publication: 2023 Jan 30.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural
    MeSH Terms:
    Tissue Inhibitor of Metalloproteinase-2*
    Cerebral Amyloid Angiopathy, Familial*
    Humans ; Tissue Inhibitor of Metalloproteinase-1 ; Matrix Metalloproteinase 14 ; Matrix Metalloproteinase 2
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Elevated expression of urokinase plasminogen activator in rodent models and patients with cerebral amyloid angiopathy.
    Autorzy:
    Vervuurt M; Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Radboud University Medical Center, Nijmegen, The Netherlands.
    Zhu X; Department of Biomedical and Pharmaceutical Sciences, George & Anne Institute for Neuroscience, University of Rhode Island, Kingston, Rhode Island, USA.
    Schrader J; Department of Biomedical and Pharmaceutical Sciences, George & Anne Institute for Neuroscience, University of Rhode Island, Kingston, Rhode Island, USA.
    de Kort AM; Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Radboud University Medical Center, Nijmegen, The Netherlands.
    Marques TM; Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Radboud University Medical Center, Nijmegen, The Netherlands.
    Kersten I; Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Radboud University Medical Center, Nijmegen, The Netherlands.
    Peters van Ton AM; Department of Intensive Care Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
    Abdo WF; Department of Intensive Care Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
    Schreuder FHBM; Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Radboud University Medical Center, Nijmegen, The Netherlands.
    Rasing I; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
    Terwindt GM; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
    Wermer MJH; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
    Greenberg SM; Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
    Klijn CJM; Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Radboud University Medical Center, Nijmegen, The Netherlands.
    Kuiperij HB; Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Radboud University Medical Center, Nijmegen, The Netherlands.
    Van Nostrand WE; Department of Biomedical and Pharmaceutical Sciences, George & Anne Institute for Neuroscience, University of Rhode Island, Kingston, Rhode Island, USA.
    Verbeek MM; Donders Institute for Brain, Cognition and Behaviour, Department of Neurology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
    Pokaż więcej
    Źródło:
    Neuropathology and applied neurobiology [Neuropathol Appl Neurobiol] 2022 Aug; Vol. 48 (5), pp. e12804. Date of Electronic Publication: 2022 Mar 09.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
    MeSH Terms:
    Cerebral Amyloid Angiopathy*/metabolism
    Urokinase-Type Plasminogen Activator*/genetics
    Urokinase-Type Plasminogen Activator*/metabolism
    Amyloid beta-Peptides/metabolism ; Animals ; Brain/metabolism ; Humans ; RNA, Messenger/metabolism ; Rats ; Rodentia/genetics ; Rodentia/metabolism
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Correction to: Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer's disease, but not in cerebral amyloid angiopathy.
    Autorzy:
    De Kort AM; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, 6500, HB, Nijmegen, The Netherlands.
    Kuiperij HB; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, 6500, HB, Nijmegen, The Netherlands.
    Alcolea D; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
    Kersten I; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, 6500, HB, Nijmegen, The Netherlands.
    Versleijen AAM; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
    Greenberg SM; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
    Stoops E; ADx NeuroSciences, Ghent, Belgium.
    Schreuder FHBM; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, 6500, HB, Nijmegen, The Netherlands.
    Klijn CJM; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, 6500, HB, Nijmegen, The Netherlands.
    Lleó A; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
    Claassen JAHR; Department of Geriatrics, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, Nijmegen, The Netherlands.
    Verbeek MM; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, 6500, HB, Nijmegen, The Netherlands. .; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands. .
    Pokaż więcej
    Źródło:
    Alzheimer's research & therapy [Alzheimers Res Ther] 2021 Nov 16; Vol. 13 (1), pp. 189. Date of Electronic Publication: 2021 Nov 16.
    Typ publikacji:
    Published Erratum
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer's disease, but not in cerebral amyloid angiopathy.
    Autorzy:
    De Kort AM; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
    Kuiperij HB; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
    Alcolea D; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
    Kersten I; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
    Versleijen AAM; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
    Greenberg SM; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
    Stoops E; ADx NeuroSciences, Ghent, Belgium.
    Schreuder FHBM; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
    Klijn CJM; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
    Lleó A; Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.; Center of Biomedical Investigation Network for Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
    Claassen JAHR; Department of Geriatrics, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, Nijmegen, The Netherlands.
    Verbeek MM; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands. .; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands. .
    Pokaż więcej
    Źródło:
    Alzheimer's research & therapy [Alzheimers Res Ther] 2021 Sep 24; Vol. 13 (1), pp. 160. Date of Electronic Publication: 2021 Sep 24.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Alzheimer Disease*/complications
    Cerebral Amyloid Angiopathy*/complications
    Amyloid beta-Peptides ; Biomarkers ; Glucose-6-Phosphate Isomerase ; Humans ; Nerve Growth Factors ; Protein Serine-Threonine Kinases
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    MFG-E8 (LACTADHERIN): a novel marker associated with cerebral amyloid angiopathy.
    Autorzy:
    Marazuela P; Neurovascular Research Laboratory, Vall d'Hebron Research Institute, Hospital Universitari Vall d´Hebron, Universitat Autónoma de Barcelona, Pg. Vall d´Hebron, 119-129, 08035, Barcelona, Spain.
    Solé M; Neurovascular Research Laboratory, Vall d'Hebron Research Institute, Hospital Universitari Vall d´Hebron, Universitat Autónoma de Barcelona, Pg. Vall d´Hebron, 119-129, 08035, Barcelona, Spain.
    Bonaterra-Pastra A; Neurovascular Research Laboratory, Vall d'Hebron Research Institute, Hospital Universitari Vall d´Hebron, Universitat Autónoma de Barcelona, Pg. Vall d´Hebron, 119-129, 08035, Barcelona, Spain.
    Pizarro J; Neurovascular Research Laboratory, Vall d'Hebron Research Institute, Hospital Universitari Vall d´Hebron, Universitat Autónoma de Barcelona, Pg. Vall d´Hebron, 119-129, 08035, Barcelona, Spain.
    Camacho J; Pathology Department, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.
    Martínez-Sáez E; Pathology Department, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.
    Kuiperij HB; Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, Radboud University Medical Center, Nijmegen, The Netherlands.
    Verbeek MM; Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
    de Kort AM; Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, Radboud University Medical Center, Nijmegen, The Netherlands.
    Schreuder FHBM; Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, Radboud University Medical Center, Nijmegen, The Netherlands.
    Klijn CJM; Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, Radboud University Medical Center, Nijmegen, The Netherlands.
    Castillo-Ribelles L; Clinical Biochemistry Department, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.
    Pancorbo O; Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Barcelona, Spain.
    Rodríguez-Luna D; Stroke Unit, Department of Neurology, Vall d'Hebron University Hospital, Barcelona, Spain.
    Pujadas F; Neurology Department, Dementia Unit, Vall d'Hebron University Hospital, Barcelona, Spain.
    Delgado P; Neurovascular Research Laboratory, Vall d'Hebron Research Institute, Hospital Universitari Vall d´Hebron, Universitat Autónoma de Barcelona, Pg. Vall d´Hebron, 119-129, 08035, Barcelona, Spain.
    Hernández-Guillamon M; Neurovascular Research Laboratory, Vall d'Hebron Research Institute, Hospital Universitari Vall d´Hebron, Universitat Autónoma de Barcelona, Pg. Vall d´Hebron, 119-129, 08035, Barcelona, Spain. .
    Pokaż więcej
    Źródło:
    Acta neuropathologica communications [Acta Neuropathol Commun] 2021 Sep 16; Vol. 9 (1), pp. 154. Date of Electronic Publication: 2021 Sep 16.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Antigens, Surface/*biosynthesis
    Brain/*metabolism
    Brain/*pathology
    Cerebral Amyloid Angiopathy/*metabolism
    Cerebral Amyloid Angiopathy/*pathology
    Milk Proteins/*biosynthesis
    Aged ; Animals ; Antigens, Surface/genetics ; Biomarkers/metabolism ; Cells, Cultured ; Cerebral Amyloid Angiopathy/genetics ; Female ; Humans ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Transgenic ; Middle Aged ; Milk Proteins/genetics
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-8 z 8

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies